查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2014986

醫用輸液袋市場：全球市場按產品類型、材料、劑量方法、滅菌方法和最終用戶分類的預測——2026-2032年

Medical Fluid Bags Market by Product Type, Material, Delivery Mode, Sterilization Method, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，醫用輸液袋市場價值將達到 35.5 億美元，到 2026 年將成長至 37.8 億美元，到 2032 年將達到 56.7 億美元，複合年成長率為 6.90%。

主要市場統計數據
基準年 2025 35.5億美元
預計年份：2026年 37.8億美元
預測年份 2032 56.7億美元
複合年成長率 (%) 6.90%

對醫用輸液袋進行權威概述，將其臨床效用、材料創新和供應鏈趨勢置於不斷發展的醫療模式中進行分析。

靜脈輸液耗材領域涵蓋了支持急診醫學、腫瘤科、營養支持和常規輸液治療等臨床工作流程的關鍵醫療輸液袋。這些設備融合了材料科學、滅菌規程、法規遵循和給藥技術，影響安全性、相容性、操作效率以及臨床效用。臨床醫生、藥劑師和供應鏈專業人員在評估輸液袋的臨床性能時，不僅關注其直接的臨床表現，還擴大考慮其與輸液泵的生命週期兼容性、與化療藥物的兼容性以及處置方式等因素，這些因素都會對環境和物流產生影響。

材料創新、與智慧劑量系統的兼容性、監管可追溯性和永續性的融合如何重塑靜脈輸液袋供應的競爭優勢。

醫用輸液袋市場正經歷一系列變革，其驅動力源自於技術、監管和永續性需求的融合。材料創新加速了輸液袋從傳統聚氯乙烯）結構轉向更注重生物相容性和減少添加劑遷移的新型配方的轉變。同時，輸液袋設計也在不斷改進，以提高輸液精度並增強與更多輸液裝置的兼容性。此外，智慧輸液系統的引入以及對互通性日益成長的需求，正在重新定義輸液袋的規格，尤其是在設備間通訊和泵浦控輸液等領域，這些領域對公差要求更高，連接器也更加標準化。

我們將評估持續的關稅措施如何改變靜脈輸液袋整個價值鏈的籌資策略、庫存結構和供應商選擇重點。

近期影響醫療設備進口的關稅政策迫使相關人員重新思考供應鏈設計和籌資策略，其累積影響遠不止於表面的貿易成本。關稅會造成摩擦，增加採購成本，並擠壓依賴跨境生產原料、零件或成品的經銷商和製造商的利潤空間。更重要的是，關稅也可能促使供應商選擇標準轉向地理位置接近性和垂直整合的供應商，以降低貿易波動帶來的風險。因此，採購團隊擴大採用供應商細分和情境分析來識別供應鏈中斷風險。

詳細的細分分析揭示了產品類型、材料選擇、最終用戶環境、交付相容性和滅菌流程如何決定規格和採購選擇。

詳細的市場細分觀點表明，不同產品類型、材料、終端用戶環境、給藥方式和滅菌技術的需求和創新促進因素各不相同。以每種產品類型（血袋、化療袋、腸外營養袋、生理食鹽水水袋）為例，每類產品都有其獨特的臨床操作需求、化學相容性限制和標籤要求，這些都會影響設計和包裝決策。例如，血袋需要與抗凝血劑嚴格相容，並能夠分離血液成分；而化療袋則必須確保藥物穩定性、安全操作和防止洩漏。

採購慣例、法規要求和製造能力的區域差異如何影響全球策略性區域市場進入決策？

區域趨勢對產品供應、監管合規管道和商業策略有顯著影響。在美洲，採購行為受到一體化醫院系統、集中採購集團以及對供應商品品管系統和國內分銷可靠性的高度重視的影響。這些特點有利於那些能夠證明其有能力處理大規模競標、嚴格遵守監管規定、及時提供技術支援並擁有穩定交貨記錄的供應商。

競爭優勢源自於技術互通性、供應鏈透明度、永續發展措施和快速監管合規性的交匯。

醫療輸液袋產業的競爭動態有利於那些整合了嚴格的品管系統、材料創新和以客戶為中心的商業化策略的企業。領先的供應商正透過改進連接器設計、加強化學相容性測試和檢驗滅菌流程來提升產品差異化，從而最大限度地降低風險並簡化臨床應用。與輸液幫浦製造商和醫療機構建立策略夥伴關係，透過展示實際應用中的互通性和工作流程效率，進一步提升了產品的價值提案。

為製造商和供應商提供可操作的策略性舉措，以確保在快速變化的環境中獲得臨床信任、應對力監管規定並保持供應鏈韌性。

產業領導企業應採取一系列切實可行的舉措，在確保臨床治療連續性的同時，增強自身競爭優勢。首先，應投資於材料科學和相容性測試，以拓展其非PVC產品線，並開發出檢驗的洗脫特性和增強的耐化學性的產品，用於敏感治療方法。這種技術導向將有助於降低臨床風險，並促進以病人安全為優先的採購談判。

摘要重點闡述了材料創新、互通性和供應鏈韌性之間的關鍵相互依存關係，以維持臨床和採購目標。

總而言之，醫用輸液袋產業正處於一個轉折點，材料創新、劑量相容性、監管以及供應鏈韌性相互交織，重新定義了採購和產品開發的優先事項。積極解決不同泵平台相容性問題、投資檢驗的非PVC替代品並加強區域生產和合規能力的供應商，將更有能力滿足不斷變化的臨床和採購需求。同時，醫療機構必須在滿足當前營運需求的同時兼顧長期生命週期考量，並將永續性和可追溯性納入採購框架，且不得損害安全性和可靠性。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 醫用輸液袋市場：依產品類型分類

  • 血袋
  • 化療袋
  • 腸外營養袋
  • 生理食鹽水水袋

第9章 醫用輸液袋市場：依材料分類

  • 不含聚氯乙烯
  • PVC

第10章：醫用輸液袋市場：依輸送方式分類

  • 重力型
  • 泵浦
    • 彈性體泵
    • 注射式幫浦
    • 容積式泵

第11章：以滅菌方法分類的醫用輸液袋市場

  • 環氧乙烷
  • 伽瑪射線

第12章 醫用輸液袋市場：依最終用戶分類

  • 門診部
  • 診所
  • 居家照護
  • 醫院

第13章 醫用輸液袋市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 醫用輸液袋市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 醫用輸液袋市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國醫用輸液袋市場

第17章：中國醫用輸液袋市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Becton, Dickinson and Company
  • Fresenius Kabi AG
  • Grifols, SA
  • ICU Medical, Inc.
  • Macopharma SAS
  • Nipro Corporation
  • Pfizer Inc.
  • Poly Medicure Ltd.
  • Sichuan Kelun Pharmaceutical Co., Ltd.
  • SSY Group Limited
  • Terumo Corporation
  • Vetter Pharma-Fertigung GmbH & Co. KG
Product Code: MRR-03602AA8F407

The Medical Fluid Bags Market was valued at USD 3.55 billion in 2025 and is projected to grow to USD 3.78 billion in 2026, with a CAGR of 6.90%, reaching USD 5.67 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.55 billion
Estimated Year [2026] USD 3.78 billion
Forecast Year [2032] USD 5.67 billion
CAGR (%) 6.90%

An authoritative orientation to medical fluid bags that situates clinical utility, material innovation, and supply chain dynamics within evolving care models

The intravenous therapy consumables landscape encompasses a critical class of medical fluid bags that sustain clinical workflows across emergency medicine, oncology, nutrition support, and routine fluid therapy. These devices constitute not only a point of clinical utility but also a nexus where material science, sterilization protocols, regulatory compliance, and delivery technologies intersect to influence safety, compatibility, and operational efficiency. Clinicians, pharmacists, and supply chain professionals increasingly evaluate fluid bag attributes beyond immediate clinical performance, considering lifecycle compatibility with pumps, compatibility with chemotherapeutic agents, and disposability considerations that affect environmental and logistical burdens.

As healthcare delivery models evolve, the role of fluid bags shifts from simple containers to components of integrated care pathways. This shift requires a more nuanced appreciation of how product type, material choice, end-use setting, delivery compatibility, and sterilization approach collectively determine procurement decisions and clinical outcomes. In turn, manufacturers and health systems must reconcile demands for robust performance with regulatory stringency and mounting pressure to reduce environmental footprint. Consequently, effective strategy in this domain rests on bridging clinical needs with supply chain agility and material innovation, while maintaining rigorous attention to patient safety and regulatory conformity.

In the pages that follow, the analysis deepens into transformative shifts reshaping the sector, regulatory and trade dynamics with global implications, segmentation-specific insights, and concrete recommendations for leaders seeking to adapt and compete in a landscape defined by technological integration and heightened quality expectations.

How converging innovation in materials, smart delivery compatibility, regulatory traceability, and sustainability is reshaping competitive advantage in fluid bag supply

The landscape for medical fluid bags is undergoing a series of transformative shifts driven by converging technological, regulatory, and sustainability imperatives. Materials innovation is accelerating the transition away from legacy polyvinyl chloride constructs toward formulations that prioritize biocompatibility and reduced additive migration; this trend is coupled with improvements in bag design that enhance dosing accuracy and compatibility with a broader array of infusion devices. Simultaneously, the adoption of smart infusion systems and increased interoperability expectations are reframing how bags are specified, particularly when device-to-device communication and pump-controlled delivery demand tighter tolerances and standardized connectors.

Regulatory agencies are also recalibrating oversight, emphasizing post-market surveillance and traceability. As a result, manufacturers and healthcare providers must invest in robust device identification practices and data capture to satisfy audit and safety requirements. At the same time, sustainability concerns are prompting procurement teams to weigh lifecycle impacts and end-of-life management in their sourcing decisions, which is leading to pilot programs for circularity and material recovery.

Taken together, these shifts are creating new vectors for differentiation: suppliers that can marry compliant materials with smart delivery compatibility and transparent supply chain practices will gain preference among hospital purchasing groups and ambulatory providers. Consequently, strategic investments in R&D, quality systems, and cross-functional partnerships will determine which organizations can sustainably scale in this evolving environment.

Assessing how sustained tariff measures are transforming sourcing strategies, inventory postures, and supplier qualification priorities across the fluid bag value chain

Recent tariff policies affecting medical device imports have prompted stakeholders to reassess supply chain design and sourcing strategies, with cumulative effects that extend beyond headline trade costs. Tariffs can introduce friction that raises landed procurement costs and compresses margins for distributors and manufacturers that rely on cross-border production for raw materials, components, or finished goods. Importantly, tariffs can also shift supplier selection criteria toward geographic proximity and vertically integrated suppliers to reduce exposure to trade volatility. Consequently, procurement teams are increasingly performing supplier segmentation and scenario analysis to identify disruptive dependencies in the supply base.

Moreover, tariffs influence inventory strategy and lead-time buffers. Organizations respond by building greater resilience into logistics planning, which can involve longer-term contracts with domestic suppliers, diversified multisourcing, or reconfigured distribution networks to mitigate customs delays and bilateral trade complexities. Regulatory alignment and quality certification requirements can complicate rapid supplier substitution; therefore, suppliers with pre-established regulatory dossiers and local manufacturing footprints achieve a competitive advantage when trade barriers amplify sourcing constraints.

In parallel, tariffs catalyze strategic conversations around nearshoring and regional production hubs that prioritize continuity of supply and regulatory proximity. While these structural adjustments can reduce trade exposure, they also necessitate fresh capital allocation decisions and longer procurement cycles to qualify new supply lines. In summary, the cumulative impact of tariff dynamics is not limited to pricing effects but manifests as systematic recalibration of supplier relationships, inventory posture, and investment priorities to protect continuity of care and preserve product quality under shifting trade regimes.

In-depth segmentation analysis revealing how product type, material selection, end-user setting, delivery compatibility, and sterilization pathways define specification and procurement choices

A granular segmentation lens reveals differentiated drivers of demand and innovation across product types, materials, end-user settings, delivery modes, and sterilization approaches. When considered by product type-blood bags, chemotherapy bags, parenteral nutrition bags, and saline bags-each category carries distinct clinical handling requirements, chemical compatibility constraints, and labeling obligations that shape design and packaging decisions. Blood bags, for instance, require strict anticoagulant compatibility and blood component separation capacities, whereas chemotherapy bags must ensure compound stability, safe handling, and spill containment features.

Material choice further delineates product pathways, with Non PVC and PVC constructions presenting trade-offs in flexibility, additive profiles, and environmental considerations. Non PVC alternatives are increasingly selected where leachables and long-term storage stability are primary concerns, while PVC remains used in contexts where cost and established supply chains predominate. End-user segmentation-ambulatory centers, clinics, home care, and hospitals-drives procurement specifications through differing operational constraints; hospitals often demand compatibility with advanced pump systems and large volume supply chains, whereas home care settings prioritize ease of use, compact packaging, and simplified instructions for caregivers.

Delivery mode distinctions between gravity and pump delivery further influence bag connector design, tubing compatibility, and structural resilience. Within pump systems, elastomeric pumps, syringe pumps, and volumetric pumps impose varying pressure and flow characteristics that affect material selection and port engineering. Finally, sterilization method choices-ethylene oxide versus gamma-carry implications for product shelf life, packaging material selection, and validation protocols. Understanding how these segment dimensions interact enables suppliers and purchasers to anticipate clinical requirements and align product development with end-user workflows and regulatory expectations.

How geographic variations in procurement practices, regulatory requirements, and manufacturing capacity are directing strategic regional go-to-market decisions across the globe

Regional dynamics exert a powerful influence on product availability, regulatory pathways, and commercial strategies. In the Americas, procurement behavior is shaped by consolidated hospital systems, centralized purchasing groups, and a high emphasis on supplier quality systems and domestic distribution reliability. These characteristics favor suppliers who can demonstrate rigorous regulatory compliance, rapid technical support, and the ability to support large-scale tenders with consistent delivery performance.

Across Europe, Middle East & Africa, the landscape is more heterogeneous, with regulatory alignment varying by sub-region and reimbursement structures influencing product selection. In this broad geography, suppliers must navigate diverse national requirements and local purchasing practices, investing in regional regulatory dossiers and localized service networks to gain traction. Conversely, Asia-Pacific demonstrates a mix of advanced manufacturing hubs and rapidly expanding healthcare infrastructure. This region combines a dual dynamic of domestic production strength and growing clinical demand, encouraging manufacturers to pursue regional partnerships, localized production, and technology transfer agreements to win large institutional accounts.

Taken together, these regional patterns underscore the importance of a geographically differentiated commercial strategy. Suppliers that tailor regulatory submissions, distribution models, and service commitments to regional expectations will achieve better access and adoption. Furthermore, regional investments in manufacturing and quality certifications can shorten time-to-contract and reduce exposure to cross-border trade disruptions, thereby enhancing resilience and customer satisfaction.

Competitive advantage emerges from the intersection of technical interoperability, supply chain transparency, sustainability credentials, and rapid regulatory responsiveness

Competitive dynamics in the medical fluid bag space favor organizations that integrate rigorous quality systems, material innovation, and customer-centric commercialization practices. Leading suppliers are investing in product differentiation through enhanced connector designs, improved chemical compatibility testing, and validated sterilization workflows to minimize risk and simplify clinical adoption. Strategic partnerships with pump manufacturers and clinical institutions further strengthen value propositions by proving real-world interoperability and workflow efficiency gains.

Operational excellence remains a core differentiator; companies that maintain transparent supplier qualification processes, robust post-market surveillance, and traceability mechanisms reduce buyer friction and build long-term trust with large healthcare purchasers. Additionally, companies focusing on sustainability credentials-such as reduced additive usage, recyclable components, or take-back pilot programs-are increasingly visible in procurement conversations where lifecycle impacts matter. Those that combine technical rigor with credible sustainability narratives can access procurement pathways that favor total-cost-of-ownership considerations.

Finally, agility in regulatory responsiveness-speedy credentialing, comprehensive technical files, and readiness for audits-provides a clear edge when providers prioritize continuity and compliance. Firms that align R&D investment with end-user feedback loops and maintain flexible manufacturing capacity are better positioned to capture opportunities that arise from evolving clinical guidelines and procurement reforms.

Actionable strategic initiatives for manufacturers and suppliers to secure clinical trust, regulatory readiness, and supply chain resilience in a rapidly evolving environment

Industry leaders should pursue a pragmatic set of actions to strengthen competitive positioning while safeguarding clinical continuity. First, invest in material science and compatibility testing to expand non-PVC offerings with validated leachables profiles and enhanced chemical resistance for sensitive therapies. This technical focus reduces clinical risk and supports procurement dialogues that emphasize patient safety.

Second, develop formal interoperability programs with pump manufacturers and clinical stakeholders to validate performance across elastomeric, syringe, and volumetric pump platforms. By demonstrating documented compatibility and providing installation and training support, suppliers can reduce barriers to adoption in hospitals and ambulatory centers. Third, prioritize regional manufacturing and regulatory readiness by establishing localized quality certifications and inventory buffers in strategic geographies such as the Americas and Asia-Pacific; this mitigates the operational effects of trade frictions and shortens lead times.

Fourth, incorporate sustainability metrics into product development and commercial materials, emphasizing lifecycle considerations without compromising sterility and performance. Finally, implement enhanced post-market surveillance and traceability systems to meet evolving regulatory expectations and provide customers with the incident visibility and corrective action assurances they increasingly require. Collectively, these measures create a defensible value proposition that supports both clinical and procurement priorities while enabling scalable growth.

This analysis synthesizes primary and secondary research methodologies to ensure a robust and verifiable evidence base. Primary inputs include structured interviews with clinical leaders, procurement directors, and device engineers to capture real-world requirements and validation criteria. These qualitative conversations are complemented by technical reviews of regulatory guidance documents, sterilization validation standards, and materials safety literature to ground assertions in accepted industry practices.

Secondary research incorporated peer-reviewed materials science publications, standards from recognized regulatory bodies, and publicly available guidance on sterilization and device compatibility. Triangulation across multiple data sources was used to confirm trends and reconcile divergent perspectives. Analytical approaches embedded scenario analysis for supply chain stress-testing and qualitative risk assessment frameworks to evaluate supplier concentration and trade exposure. Throughout, emphasis was placed on compliance with regulatory reporting norms and ensuring that technical claims are supported by cited validation methods and documented clinical use cases.

Quality control included expert review cycles with clinicians and supply chain specialists to vet conclusions and ensure practical relevance for decision-makers. This mixed-method approach balances depth of technical insight with operationally actionable recommendations, providing stakeholders with a defensible basis for procurement and product development choices.

Concluding synthesis emphasizing the critical interdependence of material innovation, interoperability, and supply chain resilience to sustain clinical and procurement objectives

In conclusion, the medical fluid bag sector is at an inflection point where material innovation, delivery compatibility, regulatory scrutiny, and supply chain resilience converge to redefine procurement and product development priorities. Suppliers that proactively address compatibility across pump platforms, invest in validated non-PVC alternatives, and strengthen regional manufacturing and regulatory capabilities will be better positioned to meet evolving clinical and procurement demands. At the same time, healthcare providers must balance immediate operational needs with longer-term lifecycle considerations, integrating sustainability and traceability into purchasing frameworks without sacrificing safety or reliability.

Going forward, collaboration among manufacturers, clinicians, and procurement teams will be essential to harmonize design, testing, and service expectations. By aligning R&D investments with real-world workflows and regulatory trends, stakeholders can reduce adoption friction and enhance patient safety. Ultimately, strategic focus on interoperability, material safety, and resilience will determine which organizations can reliably deliver value and support the continuity of care across care settings.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Medical Fluid Bags Market, by Product Type

  • 8.1. Blood Bags
  • 8.2. Chemotherapy Bags
  • 8.3. Parenteral Nutrition Bags
  • 8.4. Saline Bags

9. Medical Fluid Bags Market, by Material

  • 9.1. Non PVC
  • 9.2. PVC

10. Medical Fluid Bags Market, by Delivery Mode

  • 10.1. Gravity
  • 10.2. Pump
    • 10.2.1. Elastomeric Pump
    • 10.2.2. Syringe Pump
    • 10.2.3. Volumetric Pump

11. Medical Fluid Bags Market, by Sterilization Method

  • 11.1. Ethylene Oxide
  • 11.2. Gamma

12. Medical Fluid Bags Market, by End User

  • 12.1. Ambulatory Centers
  • 12.2. Clinics
  • 12.3. Home Care
  • 12.4. Hospitals

13. Medical Fluid Bags Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Medical Fluid Bags Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Medical Fluid Bags Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Medical Fluid Bags Market

17. China Medical Fluid Bags Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Becton, Dickinson and Company
  • 18.6. Fresenius Kabi AG
  • 18.7. Grifols, S.A.
  • 18.8. ICU Medical, Inc.
  • 18.9. Macopharma S.A.S.
  • 18.10. Nipro Corporation
  • 18.11. Pfizer Inc.
  • 18.12. Poly Medicure Ltd.
  • 18.13. Sichuan Kelun Pharmaceutical Co., Ltd.
  • 18.14. SSY Group Limited
  • 18.15. Terumo Corporation
  • 18.16. Vetter Pharma-Fertigung GmbH & Co. KG

LIST OF FIGURES

  • FIGURE 1. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MEDICAL FLUID BAGS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MEDICAL FLUID BAGS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, BY DELIVERY MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, BY STERILIZATION METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES MEDICAL FLUID BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA MEDICAL FLUID BAGS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, BY BLOOD BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, BY BLOOD BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, BY BLOOD BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, BY CHEMOTHERAPY BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, BY CHEMOTHERAPY BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, BY CHEMOTHERAPY BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, BY PARENTERAL NUTRITION BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, BY PARENTERAL NUTRITION BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, BY PARENTERAL NUTRITION BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, BY SALINE BAGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, BY SALINE BAGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, BY SALINE BAGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, BY NON PVC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, BY NON PVC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, BY NON PVC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, BY PVC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, BY PVC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, BY PVC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, BY GRAVITY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, BY GRAVITY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, BY GRAVITY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, BY PUMP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, BY PUMP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, BY PUMP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, BY PUMP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, BY ELASTOMERIC PUMP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, BY ELASTOMERIC PUMP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, BY ELASTOMERIC PUMP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, BY SYRINGE PUMP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, BY SYRINGE PUMP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, BY SYRINGE PUMP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, BY VOLUMETRIC PUMP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, BY VOLUMETRIC PUMP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, BY VOLUMETRIC PUMP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, BY ETHYLENE OXIDE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, BY ETHYLENE OXIDE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, BY ETHYLENE OXIDE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, BY GAMMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, BY GAMMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, BY GAMMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, BY AMBULATORY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, BY AMBULATORY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, BY AMBULATORY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. AMERICAS MEDICAL FLUID BAGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS MEDICAL FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS MEDICAL FLUID BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS MEDICAL FLUID BAGS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS MEDICAL FLUID BAGS MARKET SIZE, BY PUMP, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS MEDICAL FLUID BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS MEDICAL FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA MEDICAL FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. NORTH AMERICA MEDICAL FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA MEDICAL FLUID BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA MEDICAL FLUID BAGS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA MEDICAL FLUID BAGS MARKET SIZE, BY PUMP, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA MEDICAL FLUID BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA MEDICAL FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 74. LATIN AMERICA MEDICAL FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. LATIN AMERICA MEDICAL FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 76. LATIN AMERICA MEDICAL FLUID BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA MEDICAL FLUID BAGS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA MEDICAL FLUID BAGS MARKET SIZE, BY PUMP, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA MEDICAL FLUID BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA MEDICAL FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA MEDICAL FLUID BAGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA MEDICAL FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA MEDICAL FLUID BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA MEDICAL FLUID BAGS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA MEDICAL FLUID BAGS MARKET SIZE, BY PUMP, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA MEDICAL FLUID BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA MEDICAL FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE MEDICAL FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE MEDICAL FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE MEDICAL FLUID BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE MEDICAL FLUID BAGS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE MEDICAL FLUID BAGS MARKET SIZE, BY PUMP, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE MEDICAL FLUID BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE MEDICAL FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. MIDDLE EAST MEDICAL FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. MIDDLE EAST MEDICAL FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. MIDDLE EAST MEDICAL FLUID BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 98. MIDDLE EAST MEDICAL FLUID BAGS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 99. MIDDLE EAST MEDICAL FLUID BAGS MARKET SIZE, BY PUMP, 2018-2032 (USD MILLION)
  • TABLE 100. MIDDLE EAST MEDICAL FLUID BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST MEDICAL FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. AFRICA MEDICAL FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. AFRICA MEDICAL FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. AFRICA MEDICAL FLUID BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 105. AFRICA MEDICAL FLUID BAGS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 106. AFRICA MEDICAL FLUID BAGS MARKET SIZE, BY PUMP, 2018-2032 (USD MILLION)
  • TABLE 107. AFRICA MEDICAL FLUID BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA MEDICAL FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC MEDICAL FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC MEDICAL FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC MEDICAL FLUID BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC MEDICAL FLUID BAGS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC MEDICAL FLUID BAGS MARKET SIZE, BY PUMP, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC MEDICAL FLUID BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC MEDICAL FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. ASEAN MEDICAL FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. ASEAN MEDICAL FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. ASEAN MEDICAL FLUID BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 120. ASEAN MEDICAL FLUID BAGS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 121. ASEAN MEDICAL FLUID BAGS MARKET SIZE, BY PUMP, 2018-2032 (USD MILLION)
  • TABLE 122. ASEAN MEDICAL FLUID BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN MEDICAL FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. GCC MEDICAL FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GCC MEDICAL FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. GCC MEDICAL FLUID BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 127. GCC MEDICAL FLUID BAGS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 128. GCC MEDICAL FLUID BAGS MARKET SIZE, BY PUMP, 2018-2032 (USD MILLION)
  • TABLE 129. GCC MEDICAL FLUID BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 130. GCC MEDICAL FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPEAN UNION MEDICAL FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPEAN UNION MEDICAL FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPEAN UNION MEDICAL FLUID BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPEAN UNION MEDICAL FLUID BAGS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPEAN UNION MEDICAL FLUID BAGS MARKET SIZE, BY PUMP, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPEAN UNION MEDICAL FLUID BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPEAN UNION MEDICAL FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. BRICS MEDICAL FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. BRICS MEDICAL FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. BRICS MEDICAL FLUID BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 141. BRICS MEDICAL FLUID BAGS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 142. BRICS MEDICAL FLUID BAGS MARKET SIZE, BY PUMP, 2018-2032 (USD MILLION)
  • TABLE 143. BRICS MEDICAL FLUID BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 144. BRICS MEDICAL FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. G7 MEDICAL FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. G7 MEDICAL FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. G7 MEDICAL FLUID BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 148. G7 MEDICAL FLUID BAGS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 149. G7 MEDICAL FLUID BAGS MARKET SIZE, BY PUMP, 2018-2032 (USD MILLION)
  • TABLE 150. G7 MEDICAL FLUID BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 151. G7 MEDICAL FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. NATO MEDICAL FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. NATO MEDICAL FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. NATO MEDICAL FLUID BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 155. NATO MEDICAL FLUID BAGS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 156. NATO MEDICAL FLUID BAGS MARKET SIZE, BY PUMP, 2018-2032 (USD MILLION)
  • TABLE 157. NATO MEDICAL FLUID BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 158. NATO MEDICAL FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL MEDICAL FLUID BAGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. UNITED STATES MEDICAL FLUID BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 161. UNITED STATES MEDICAL FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. UNITED STATES MEDICAL FLUID BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 163. UNITED STATES MEDICAL FLUID BAGS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 164. UNITED STATES MEDICAL FLUID BAGS MARKET SIZE, BY PUMP, 2018-2032 (USD MILLION)
  • TABLE 165. UNITED STATES MEDICAL FLUID BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 166. UNITED STATES MEDICAL FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. CHINA MEDICAL FLUID BAGS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 168. CHINA MEDICAL FLUID BAGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. CHINA MEDICAL FLUID BAGS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 170. CHINA MEDICAL FLUID BAGS MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 171. CHINA MEDICAL FLUID BAGS MARKET SIZE, BY PUMP, 2018-2032 (USD MILLION)
  • TABLE 172. CHINA MEDICAL FLUID BAGS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 173. CHINA MEDICAL FLUID BAGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)